Medications for alcohol use disorder
Pro Research Analysisby 
Searched over 200M research papers
FDA-Approved Medications for Alcohol Use Disorder
Three main medications are approved by the U.S. Food and Drug Administration (FDA) for treating alcohol use disorder (AUD): naltrexone, acamprosate, and disulfiram. Naltrexone and acamprosate are effective in reducing alcohol consumption and increasing abstinence rates, though their effects are generally modest. Disulfiram has been used for many years, but its effectiveness is inconsistent, especially outside of supervised settings Kranzler2023Poorman2024Litten2016+4 MORE.
Off-Label and Investigational Medications for AUD
Several other medications are used off-label or are under investigation for AUD. These include gabapentin, topiramate, baclofen, varenicline, ondansetron, and others. Gabapentin and topiramate have shown evidence of reducing heavy drinking days, while baclofen and varenicline may also help reduce alcohol use. Ondansetron may be particularly helpful in certain subpopulations. However, the effectiveness of these medications varies, and more research is needed to confirm their benefits and safety Kranzler2023Poorman2024Litten2016+5 MORE.
Mechanisms of Action and Clinical Use
- Naltrexone: An opioid antagonist that reduces the rewarding effects of alcohol, helping to decrease cravings and heavy drinking.
- Acamprosate: Modulates glutamatergic neurotransmission, supporting abstinence in those who have already stopped drinking.
- Disulfiram: Causes unpleasant physical reactions when alcohol is consumed, acting as a deterrent.
- Gabapentin and Topiramate: Affect GABA and glutamate neurotransmission, reducing cravings and heavy drinking.
- Baclofen: A GABA-B receptor agonist, sometimes used in patients with liver disease due to its safety profile Akbar2017Kranzler2023Poorman2024+7 MORE.
Effectiveness and Safety in Special Populations
Medications for AUD are effective in promoting abstinence even in patients with alcohol-associated cirrhosis, with a good safety profile. Baclofen, in particular, has been studied in this population and found to be both effective and safe. However, more research is needed for patients with advanced liver disease .
Underutilization and Barriers to Treatment
Despite the availability of effective medications, they are significantly underutilized. Only a small percentage of people with AUD receive pharmacotherapy, often due to lack of awareness, stigma, or limited access to specialized care. There is a need for systematic policies to expand the use of these medications in both inpatient and outpatient settings Kranzler2023Poorman2024Burnette2022+2 MORE.
Personalized and Future Approaches
Given the heterogeneity of AUD, no single medication works for everyone. Personalized treatment strategies, including pharmacogenetic approaches, are being explored but are not yet ready for routine clinical use. Ongoing research is focused on developing new medications and improving access to existing treatments Akbar2017Kranzler2023Litten2016+3 MORE.
Conclusion
Medications for alcohol use disorder, including FDA-approved and off-label options, can help reduce drinking and support abstinence. While naltrexone, acamprosate, and disulfiram are the main approved treatments, other medications like gabapentin, topiramate, and baclofen offer additional options, especially for those who do not respond to first-line therapies. Despite their proven benefits, these medications remain underused, highlighting the need for greater awareness, access, and personalized treatment approaches.
Sources and full results
Most relevant research papers on this topic